RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $17,000 | -91.5% | 20,222 | -44.6% | 0.00% | – |
| Q1 2022 | $201,000 | -43.1% | 36,476 | 0.0% | 0.00% | – |
| Q4 2021 | $353,000 | -45.2% | 36,476 | +1.2% | 0.00% | – |
| Q3 2021 | $644,000 | +48.7% | 36,040 | +103.0% | 0.00% | – |
| Q2 2021 | $433,000 | -8.1% | 17,757 | 0.0% | 0.00% | – |
| Q1 2021 | $471,000 | +395.8% | 17,757 | +41.4% | 0.00% | – |
| Q4 2020 | $95,000 | – | 12,561 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |